検索結果 - Hans‐Jochem Kolb
-
1
Graft-versus-leukemia effects of transplantation and donor lymphocytes 著者: Hans‐Jochem Kolb
出版事項 2008Revisão -
2
Commentary on” The FLAMSA Concept Past and Future” 著者: Hans‐Jochem Kolb, Belinda Pinto Simões, Christoph Schmid
出版事項 2022Artigo -
3
Infection and GVHD 著者: Hans‐Jochem Kolb, Daniela Weber, Belinda Pinto Simões, Ernst Holler
出版事項 2018Artigo -
4
-
5
-
6
Plasminogen Activator Inhibitor-1 Confirms the Diagnosis of Hepatic Veno-Occlusive Disease in Patients With Hyperbilirubinemia After Bone Marrow Transplantation 著者: Christoph Salat, Ernst Holler, Hans‐Jochem Kolb, Brigitte Reinhardt, Rudolf Pihusch, W. Wilmanns, Erhard Hiller
出版事項 1997Artigo -
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 著者: Eva M. Weissinger, Eric Schiffer, Bernd Hertenstein, James L.M. Ferrara, Ernst Holler, Michael Stadler, Hans‐Jochem Kolb, Axel R. Zander, Petra Zürbig, Markus Kellmann, Arnold Ganser
出版事項 2007Artigo -
15
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells 著者: Andreas Moosmann, Iris Bigalke, Johanna Tischer, Leah Schirrmann, Julitta Kasten, Stefanie Tippmer, Marina Leeping, Dušan Prevalšek, Gundula Jaeger, Georg Ledderose, Josef Mautner, Wolfgang Hammerschmidt, Dolores J. Schendel, Hans‐Jochem Kolb
出版事項 2010Artigo -
16
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Fac... 著者: Christoph Schmid, Myriam Labopin, Arnon Nagler, Martin Bornhäuser, Jürgen Finke, Athanasios Fassas, Liisa Volin, Günhan Gürman, Johan Maertens, Pierre Bordigoni, Ernst Holler, Gerhard Ehninger, Emmanuelle Polge, Norbert Claude Gorin, Hans-Jochem Kolb, Vanderson Rocha
出版事項 2007Artigo -
17
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose 著者: Cesare Guglielmi, William Arcese, Francesco Dazzi, Ronald Brand, Donald Bunjes, Leo F. Verdonck, A Schattenberg, Hans-Jochem Kolb, Per Ljungman, Agnès Devergie, Andrea Bacigalupo, Marta Gómez, Mauricette Michallet, Ahmet Elmaağaclı, Aloïs Gratwohl, Jane Apperley, Dietger Niederwieser
出版事項 2002Artigo -
18
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation 著者: Nicole Engel, Alicia Rovó, Manuela Badoglio, Myriam Labopin, Grzegorz Basak, Yves Béguin, D Guyotat, Per Ljungman, Arnon Nagler, A Schattenberg, Thomas Schroeder, Wilfried Schroyens, Johanna Tischer, Gèrard Socié, Hans‐Jochem Kolb, André Tichelli, Nina Salooja, Rafael F. Duarte
出版事項 2018Artigo -
19
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease 著者: Mary E.D. Flowers, Jane F. Apperley, Koen van Besien, Ahmet Elmaağaclı, Andrew Grigg, Vijay Reddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luís Fernando S. Bouzas, Mauricette Michallet, H. Miles Prince, Robert Knobler, Dennis Parenti, José Luis Rodríguez Gallo, Hildegard Greinix
出版事項 2008Artigo -
20
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation 著者: Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, Bernd Hertenstein, Eva M. Weissinger, Donald Bunjes, Stephanie von Harsdorf, Christoph Scheid, Udo Holtick, Hildegard Greinix, Felix Keil, Barbara Schneider, Michael Sandherr, Gesine Bug, Johanna Tischer, Georg Ledderose, Michael Hallek, Wolfgang Hiddemann, Hans-Jochem Kolb
出版事項 2006Artigo
関連主題
Medicine
Internal medicine
Transplantation
Immunology
Biology
Hematopoietic stem cell transplantation
Surgery
Gastroenterology
Leukemia
Genetics
Myeloid leukemia
Oncology
Stem cell
Bone marrow
Chemotherapy
Graft-versus-host disease
Haematopoiesis
Randomized controlled trial
Cancer research
Disease
Biochemistry
Cyclophosphamide
Gene
Hematology
Imatinib
Acute leukemia
Chronic myelogenous leukemia
Cumulative incidence
Environmental health
Imatinib mesylate